Merck & Co., Inc. Other Comprehensive Income (Loss), Pension and Other Postretirement Benefit Plans, Adjustment, Net of Tax (Deprecated 2012-01-31)
Merck & Co., Inc. (MRK) reported Other Comprehensive Income (Loss), Pension and Other Postretirement Benefit Plans, Adjustment, Net of Tax (Deprecated 2012-01-31) of -$303.00 million for the 12-month period ending 2011-12-31, per its 10-K filed 2012-02-28.
Discontinued › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPeriodIncreaseDecrease · last filed 2012-05-08
- Merck & Co., Inc. other comprehensive income (loss), pension and other postretirement benefit plans, adjustment, net of tax (deprecated 2012-01-31) for the quarter ending 2011-12-31 was -$362.00M, a 227.46% decline year-over-year.
- Merck & Co., Inc. other comprehensive income (loss), pension and other postretirement benefit plans, adjustment, net of tax (deprecated 2012-01-31) for the quarter ending 2011-09-30 was $31.00M, a 47.62% increase year-over-year.
- Merck & Co., Inc. other comprehensive income (loss), pension and other postretirement benefit plans, adjustment, net of tax (deprecated 2012-01-31) for the quarter ending 2011-06-30 was $10.00M, a 83.87% decline year-over-year.
- Merck & Co., Inc. other comprehensive income (loss), pension and other postretirement benefit plans, adjustment, net of tax (deprecated 2012-01-31) for the quarter ending 2011-03-31 was $18.00M, a 69.49% decline year-over-year.
- Merck & Co., Inc. other comprehensive income (loss), pension and other postretirement benefit plans, adjustment, net of tax (deprecated 2012-01-31) for fiscal 2011 was -$303.00M, a 171.13% decline from fiscal 2010.
- Merck & Co., Inc. other comprehensive income (loss), pension and other postretirement benefit plans, adjustment, net of tax (deprecated 2012-01-31) for fiscal 2010 was $426.00M, a 49.47% increase from fiscal 2009.
- Merck & Co., Inc. other comprehensive income (loss), pension and other postretirement benefit plans, adjustment, net of tax (deprecated 2012-01-31) for fiscal 2009 was $285.00M.
- Merck & Co., Inc. other comprehensive income (loss), pension and other postretirement benefit plans, adjustment, net of tax (deprecated 2012-01-31) for fiscal 2008 was -$1.76B.
| Period end | Other Comprehensive Income (Loss), Pension and Other Postretirement Benefit Plans, Adjustment, Net of Tax (Deprecated 2012-01-31) 3 month | Other Comprehensive Income (Loss), Pension and Other Postretirement Benefit Plans, Adjustment, Net of Tax (Deprecated 2012-01-31) 6 month | Other Comprehensive Income (Loss), Pension and Other Postretirement Benefit Plans, Adjustment, Net of Tax (Deprecated 2012-01-31) 9 month | Other Comprehensive Income (Loss), Pension and Other Postretirement Benefit Plans, Adjustment, Net of Tax (Deprecated 2012-01-31) 12 month |
|---|---|---|---|---|
| 2011-12-31 | -$362.00M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-28 | -$331.00M derived: sum of 2 quarters · filed 2012-02-28 | -$321.00M derived: sum of 3 quarters · filed 2012-02-28 | -$303.00M 10-K · filed 2012-02-28 |
| 2011-09-30 | $31.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-08 | $41.00M derived: sum of 2 quarters · filed 2011-11-08 | $59.00M 10-Q · filed 2011-11-08 | $343.00M derived: sum of 4 quarters · filed 2012-05-08 |
| 2011-06-30 | $10.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-08 | $28.00M 10-Q · filed 2011-08-08 | $312.00M derived: sum of 3 quarters · filed 2012-05-08 | $333.00M derived: sum of 4 quarters · filed 2012-05-08 |
| 2011-03-31 | $18.00M 10-Q · filed 2012-05-08 | $302.00M derived: sum of 2 quarters · filed 2012-05-08 | $323.00M derived: sum of 3 quarters · filed 2012-05-08 | $385.00M derived: sum of 4 quarters · filed 2012-05-08 |
| 2010-12-31 | $284.00M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-28 | $305.00M derived: sum of 2 quarters · filed 2012-02-28 | $367.00M derived: sum of 3 quarters · filed 2012-02-28 | $426.00M 10-K · filed 2012-02-28 |
| 2010-09-30 | $21.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-08 | $83.00M derived: sum of 2 quarters · filed 2011-11-08 | $142.00M 10-Q · filed 2011-11-08 | |
| 2010-06-30 | $62.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-08 | $121.00M 10-Q · filed 2011-08-08 | ||
| 2010-03-31 | $59.00M 10-Q · filed 2011-05-09 | |||
| 2009-12-31 | $285.00M 10-K · filed 2012-02-28 | |||
| 2008-12-31 | -$1.76B 10-K · filed 2011-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |